TANG CAPITAL MANAGEMENT LLC Diversified Active

CIK: 0001232621 · Show all filings

Period: Q2 2015 (← Previous) (Next →)

Filing Date: Aug 14, 2015

Total Value ($000): $329,583 (87.7% shares, 12.3% debt)

Holdings (6)

HRTX HERON THERAPEUTICS INC 49.1%

Value ($000) $161,746 Shares 5,190,837 Est. Cost $12.86 Unrealized +46.3%

— LA JOLLA PHARMACEUTICAL CO 19.8%

Value ($000) $65,318 Shares 2,664,970 Est. Cost $13.16 Unrealized —

— BIO-REFERENCE LABS INC 11.3%

Value ($000) $37,125 Shares 900,000 Est. Cost $41.25 Unrealized —

— OPKO HEALTH INC 10.1%

Value ($000) $33,131 Shares 14,000,000 Est. Cost $1.47 Unrealized —

BMRN BIOMARIN PHARMACEUTICAL INC 7.6%

Value ($000) $24,935 Shares 182,300 Est. Cost $62.32 Unrealized +98.9%

— MERRIMACK PHARMACEUTICALS INC 2.2%

Value ($000) $7,328 Shares 3,500,000 Est. Cost $1.36 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
HRTX	HERON THERAPEUTICS INC	5,190,837	$161,746	49.1%	$12.86	+46.3%	COM	427746102
—	LA JOLLA PHARMACEUTICAL CO	2,664,970	$65,318	19.8%	$13.16	—	COM	503459604
—	BIO-REFERENCE LABS INC	900,000	$37,125	11.3%	$41.25	—	COM	09057G602
—	OPKO HEALTH INC	14,000,000	$33,131	10.1%	$1.47	—	DEBT 3.0% 2/1/33	68375NAB9
BMRN	BIOMARIN PHARMACEUTICAL INC	182,300	$24,935	7.6%	$62.32	+98.9%	COM	09061G101
—	MERRIMACK PHARMACEUTICALS INC	3,500,000	$7,328	2.2%	$1.36	—	NOTE 4.5% 7/15/20	590328AA8